<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Assessments</a></li><li><a href="#id7">Plan Of Treatment</a></li><li><a href="#id8">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">angiotensin-converting enzyme inhibitor (FN)</td><td>ACE INHIBITORS, lisinopril</td><td ID="reaction1">lip swollen</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">enalapril</td><td>enalapril</td><td ID="reaction2">angioedema</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy3">Substance with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor mechanism of action (substance)</td><td>Statins</td><td ID="reaction3">myalgias</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>follow up</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Meloxicam 15 MG</td><td ID="instruction1">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Diclofenac Sodium 75 MG</td><td ID="instruction2">1 tablet as needed Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">metFORMIN HCl 500 MG</td><td ID="instruction3">1 tablet with a meal Orally twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Glimepiride 4 MG</td><td ID="instruction4">1 tablet before a meal Orally twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">traMADol HCl 50 MG</td><td ID="instruction5">1 tablet as needed Orally Twice a day for NON-ACUTE PAIN for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">True metrix lancets lancets</td><td ID="instruction6">USE DAILY AS DIRECTED for 100</td><td ID="medication6notes">*Reorder from Medispan for eRx and Interaction Alerts*</td><td/><td/><td>Unknown</td></tr><tr><td ID="medication7">Carvedilol 6.25 MG</td><td ID="instruction7">TAKE 1 TABLET BY MOUTH TWICE DAILY WITH FOOD for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">True Metrix Pro Blood Glucose -</td><td ID="instruction8">dermally dermally testing twice a day for 90 days</td><td ID="medication8notes">Dx: E11.42</td><td>[REDACTED]</td><td/><td>Unknown</td></tr><tr><td ID="medication9">Gabapentin 300 MG</td><td ID="instruction9">1 capsule Orally Three times per day AC for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">cloNIDine HCl 0.1 MG</td><td ID="instruction10">one tablet Orally Twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Lipitor 80 MG</td><td ID="instruction11">1 tablet Orally Once a day</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication12">ReliOn True Metrix Test Strips test strips</td><td ID="instruction12">USE DAILY AS DIRECTED for 100</td><td ID="medication12notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Unknown</td></tr><tr><td ID="medication13">QUEtiapine Fumarate 25 MG</td><td ID="instruction13">1 tablet at bedtime Orally Once a day</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication14">True Metrix Air Glucose Meter w/Device</td><td ID="instruction14">dermally dermally twice a day for 90 days</td><td ID="medication14notes">Dx: E11.42</td><td>[REDACTED]</td><td/><td>Unknown</td></tr><tr><td ID="medication15">Sucralfate 1 GM</td><td ID="instruction15"><p>1 tablet on an empty stomach Orally Four times a day</p><p>As needed</p></td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication16">Finasteride 5 MG</td><td ID="instruction16">TAKE 1 TABLET BY MOUTH EVERY DAY Orally Once a day for 90 days</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication17">Clopidogrel Bisulfate 75 MG</td><td ID="instruction17">1 tablet Orally Once a day</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication18">Furosemide 40 MG</td><td ID="instruction18">1/2 tablet Orally Once a day</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication19">Fluconazole 100 MG</td><td ID="instruction19">1 tablet Orally once a week for 14 days</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication20">Latanoprost 0.005 %</td><td ID="instruction20">1 drop into affected eye in the evening Ophthalmic Once a day for 90 days</td><td/><td/><td/><td>Unknown</td></tr><tr><td ID="medication21">Sildenafil Citrate 100 MG</td><td ID="instruction21">1 tablet as needed Orally Once a day for 30 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication22">Amoxicillin-Pot Clavulanate 875-125 MG</td><td ID="instruction22">one tablet with food Orally twice a day for 10 day(s)</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication23">DULoxetine HCl 30 MG</td><td ID="instruction23">1 capsule Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication24">Aspirin 81 MG</td><td ID="instruction24">1 tablet Orally Once a day</td><td/><td/><td/><td>Unknown</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Temple Terrace</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Coronary artery disease involving coronary bypass graft of native heart with unstable angina pectoris I25.700 ; Non-ST elevation MI (NSTEMI) I21.4 ; S/P left atrial appendage ligation Z98.890 ; Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I12.9 ; Chronic kidney disease, stage 2 (mild) N18.2 ; Hypercholesteremia E78.00 ; Atherosclerosis of aorta I70.0 ; Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.51 ; Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin E11.42 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; Type 2 diabetes mellitus with diabetic neuropathy, unspecified E11.40 ; Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin E11.69 ; Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type K92.2 ; Gastro-esophageal reflux disease without esophagitis K21.9 ; ISCHEMIC COLITIS K55.9 ; Primary osteoarthritis involving multiple joints M15.9 ; Spinal enthesopathy, multiple sites in spine M46.09 ; Opioid dependence, uncomplicated F11.20 ; Age-related osteoporosis without current pathological fracture M81.0 ; Erectile dysfunction due to arterial insufficiency N52.01 ; Degenerative disease of nervous system, unspecified G31.9 ; Alzheimer's disease with early onset G30.0 ; Dementia in other diseases classified elsewhere, mild, with mood disturbance F02.A3 ; Benign prostatic hyperplasia with lower urinary tract symptoms N40.1 ; Other obstructive and reflux uropathy N13.8 ; Thrombocytopenia D69.6 ; Major depressive disorder, recurrent, moderate F33.1 and Swelling of left lower extremity M79.89</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Coronary artery disease involving coronary bypass graft of native heart with unstable angina pectoris (ICD-10 - I25.700)</td><td/><td>Maintain good control of BP and Lipids, Monitor for symptoms. Maintain good control of BP and Lipids, Monitor for symptoms.</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Non-ST elevation MI (NSTEMI) (ICD-10 - I21.4)</td><td/><td>Maintain good control of BP and Lipids, Monitor for symptoms. </td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>S/P left atrial appendage ligation (ICD-10 - Z98.890)</td><td/><td>Monitor for now. Follow- up </td><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I12.9)</td><td/><td>Low Sodium Diet, Weight Reduction. Monitor. </td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Chronic kidney disease, stage 2 (mild) (ICD-10 - N18.2)</td><td/><td>In order to preserve renal function we need strict control of blood pressure - which should be less than 140/90 per JNC-8 guidelines; strict control of the LDL cholesterol which should be below 100, using statins if necessary. I encourage you to drink 50 ounces of fluids daily, and follow a low sodium diet. Avoid nephrotoxins (like NSAIDs). Monitor. </td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Hypercholesteremia (ICD-10 - E78.00)</td><td/><td>Low cholesterol / high fiber diet. Monitor. </td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Atherosclerosis of aorta (ICD-10 - I70.0)</td><td/><td>Maintain good control of BP and LIPIDS. Monitor for symptoms. </td><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene (ICD-10 - E11.51)</td><td/><td>GLIMEPIRIDE TO 4MG BID W/ METFORMIN 500MG BID. Monitor vacular signs and symptoms going forward - pvd present as a complication of diabetes.</td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin (ICD-10 - E11.42)</td><td/><td>he REFUSES insulin or any injectable therapy. . Monitor neurologic signs and symptoms going forward - neuropathy present as a complication of diabetes. </td><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td><p>Adjust therapy to improve A1C- follow-up to monitor A1C. GFR, and urine proteins.</p><p>he REFUSES insulin or any injectable therapy.</p></td><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic neuropathy, unspecified (ICD-10 - E11.40)</td><td/><td>Stressed healthy diet and maintaining a healthy weight. Encourage monitoring blood glucose levels between office visits. Adjust therapy to improve A1C and BP levels- follow-up to monitor A1C, GFR, and urine proteins. \</td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin (ICD-10 - E11.69)</td><td/><td>Monitor cardiovascular signs and symptoms going forward- Hyperlipidemia present as a complication of diabetes</td><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type (ICD-10 - K92.2)</td><td/><td>Followup with Dr. Mompi. Colonoscopy study pending.  </td><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Gastro-esophageal reflux disease without esophagitis (ICD-10 - K21.9)</td><td/><td>Watch alcohol, eating too close to bedtime, chocolate, caffeine, greasy, spicy, and acidic foods. Monitor symptoms. </td><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>ISCHEMIC COLITIS (ICD-10 - K55.9)</td><td>[REDACTED]</td><td>Monitor for now. Follow- up</td><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Primary osteoarthritis involving multiple joints (ICD-10 - M15.9)</td><td/><td>The patient meets established guidelines for the management of non-malignant pain. Discussed the risks, benefits, and side effects of medication treatment including but not limited to medication abuse, tolerance, sedation, addiction and dependence. The PDMP (Eforsce) and random drug screenings are monitored for compliance. Current therapy improved the patient's functional capacity and quality of life. </td><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Spinal enthesopathy, multiple sites in spine (ICD-10 - M46.09)</td><td/><td>Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms. </td><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Opioid dependence, uncomplicated (ICD-10 - F11.20)</td><td/><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high-risk situations; Use has resulted in a reduction of recreational, social and/or occupational activities; Note: Physical dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy. Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use;</td><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Age-related osteoporosis without current pathological fracture (ICD-10 - M81.0)</td><td/><td>Supplement calcium and Vitamin D. DEXA every two years. </td><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Erectile dysfunction due to arterial insufficiency (ICD-10 - N52.01)</td><td/><td>Usually, a man takes 1 tablet 30 minutes to 1 hour before he plans to have sex. Sildenafil works for 4-8 hours; vardenafil works for up to 8 hours; and tadalafil works for up to 36 hours. You should not take more than 1 dose in 24 hours. Possible side effects: flushing, stomach upset, runny nose or vision changes are rare.</td><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Degenerative disease of nervous system, unspecified (ICD-10 - G31.9)</td><td/><td>Monitor for now. Follow-up. </td><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Alzheimer's disease with early onset (ICD-10 - G30.0)</td><td/><td>Improved mentation at present. MOnitor mental status going forward.  </td><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Dementia in other diseases classified elsewhere, mild, with mood disturbance (ICD-10 - F02.A3)</td><td/><td>Improved mentation at present. MOnitor mental status going forward.  </td><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Benign prostatic hyperplasia with lower urinary tract symptoms (ICD-10 - N40.1)</td><td/><td><p/><p> </p><p>  </p><p>  Mild symptoms can be decreased by reducing you liquid</p><p>  intake, avoiding caffeine and alcohol and by preventing constipation. Monitor</p><p>  symptoms.    </p></td><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Other obstructive and reflux uropathy (ICD-10 - N13.8)</td><td/><td><p/><p> </p><p>  </p><p>  Mild symptoms can be decreased by reducing you liquid</p><p>  intake, avoiding caffeine and alcohol and by preventing constipation. Monitor</p><p>  symptoms.</p><p>    </p></td><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Thrombocytopenia (ICD-10 - D69.6)</td><td/><td>Monitor for now. Follow-up. </td><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Major depressive disorder, recurrent, moderate (ICD-10 - F33.1)</td><td/><td>monitor, continue current meds  </td><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Swelling of left lower extremity (ICD-10 - M79.89)</td><td/><td>Presentation more c/w phlebitis, but need to rule out DVT.  Cover with Augmentin bid / elevate / warm compresses. Check STAT DUPLEX US TO RULE-OUT DVT. </td><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Meloxicam 15 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Diclofenac Sodium 75 MG</td><td>1 tablet as needed Orally Twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds3">metFORMIN HCl 500 MG</td><td>1 tablet with a meal Orally twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds4">Glimepiride 4 MG</td><td>1 tablet before a meal Orally twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds5">traMADol HCl 50 MG</td><td>1 tablet as needed Orally Twice a day for NON-ACUTE PAIN for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds6">Carvedilol 6.25 MG</td><td>TAKE 1 TABLET BY MOUTH TWICE DAILY WITH FOOD for 90</td><td/><td/><td/></tr><tr><td ID="potMeds7">Gabapentin 300 MG</td><td>1 capsule Orally Three times per day AC for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds8">cloNIDine HCl 0.1 MG</td><td>one tablet Orally Twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds9">Sildenafil Citrate 100 MG</td><td>1 tablet as needed Orally Once a day for 30 day(s)</td><td/><td/><td/></tr><tr><td ID="potMeds10">Amoxicillin-Pot Clavulanate 875-125 MG</td><td>one tablet with food Orally twice a day for 10 day(s)</td><td/><td/><td/></tr><tr><td ID="potMeds11">DULoxetine HCl 30 MG</td><td>1 capsule Orally Once a day for 90 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Coronary artery disease involving coronary bypass graft of native heart with unstable angina pectoris</td><td>Maintain good control of BP and Lipids, Monitor for symptoms. Maintain good control of BP and Lipids, Monitor for symptoms.</td></tr><tr><td ID="instructionpot2">Non-ST elevation MI (NSTEMI)</td><td>Maintain good control of BP and Lipids, Monitor for symptoms. </td></tr><tr><td ID="instructionpot3">S/P left atrial appendage ligation</td><td>Monitor for now. Follow- up </td></tr><tr><td ID="instructionpot4">Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td><td>Low Sodium Diet, Weight Reduction. Monitor. </td></tr><tr><td ID="instructionpot5">Chronic kidney disease, stage 2 (mild)</td><td>In order to preserve renal function we need strict control of blood pressure - which should be less than 140/90 per JNC-8 guidelines; strict control of the LDL cholesterol which should be below 100, using statins if necessary. I encourage you to drink 50 ounces of fluids daily, and follow a low sodium diet. Avoid nephrotoxins (like NSAIDs). Monitor. </td></tr><tr><td ID="instructionpot6">Hypercholesteremia</td><td>Low cholesterol / high fiber diet. Monitor. </td></tr><tr><td ID="instructionpot7">Atherosclerosis of aorta</td><td>Maintain good control of BP and LIPIDS. Monitor for symptoms. </td></tr><tr><td ID="instructionpot8">Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</td><td>GLIMEPIRIDE TO 4MG BID W/ METFORMIN 500MG BID. Monitor vacular signs and symptoms going forward - pvd present as a complication of diabetes.</td></tr><tr><td ID="instructionpot9">Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin</td><td>he REFUSES insulin or any injectable therapy. . Monitor neurologic signs and symptoms going forward - neuropathy present as a complication of diabetes. </td></tr><tr><td ID="instructionpot10">Type 2 diabetes mellitus with diabetic chronic kidney disease</td><td><p>Adjust therapy to improve A1C- follow-up to monitor A1C. GFR, and urine proteins.</p><p>he REFUSES insulin or any injectable therapy.</p></td></tr><tr><td ID="instructionpot11">Type 2 diabetes mellitus with diabetic neuropathy, unspecified</td><td>Stressed healthy diet and maintaining a healthy weight. Encourage monitoring blood glucose levels between office visits. Adjust therapy to improve A1C and BP levels- follow-up to monitor A1C, GFR, and urine proteins. \</td></tr><tr><td ID="instructionpot12">Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</td><td>Monitor cardiovascular signs and symptoms going forward- Hyperlipidemia present as a complication of diabetes</td></tr><tr><td ID="instructionpot13">Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type</td><td>Followup with Dr. Mompi. Colonoscopy study pending.  </td></tr><tr><td ID="instructionpot14">Gastro-esophageal reflux disease without esophagitis</td><td>Watch alcohol, eating too close to bedtime, chocolate, caffeine, greasy, spicy, and acidic foods. Monitor symptoms. </td></tr><tr><td ID="instructionpot15">ISCHEMIC COLITIS</td><td>Monitor for now. Follow- up</td></tr><tr><td ID="instructionpot16">Primary osteoarthritis involving multiple joints</td><td>The patient meets established guidelines for the management of non-malignant pain. Discussed the risks, benefits, and side effects of medication treatment including but not limited to medication abuse, tolerance, sedation, addiction and dependence. The PDMP (Eforsce) and random drug screenings are monitored for compliance. Current therapy improved the patient's functional capacity and quality of life. </td></tr><tr><td ID="instructionpot17">Spinal enthesopathy, multiple sites in spine</td><td>Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms. </td></tr><tr><td ID="instructionpot18">Opioid dependence, uncomplicated</td><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high-risk situations; Use has resulted in a reduction of recreational, social and/or occupational activities; Note: Physical dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy. Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use;</td></tr><tr><td ID="instructionpot19">Age-related osteoporosis without current pathological fracture</td><td>Supplement calcium and Vitamin D. DEXA every two years. </td></tr><tr><td ID="instructionpot20">Erectile dysfunction due to arterial insufficiency</td><td>Usually, a man takes 1 tablet 30 minutes to 1 hour before he plans to have sex. Sildenafil works for 4-8 hours; vardenafil works for up to 8 hours; and tadalafil works for up to 36 hours. You should not take more than 1 dose in 24 hours. Possible side effects: flushing, stomach upset, runny nose or vision changes are rare.</td></tr><tr><td ID="instructionpot21">Degenerative disease of nervous system, unspecified</td><td>Monitor for now. Follow-up. </td></tr><tr><td ID="instructionpot22">Alzheimer's disease with early onset</td><td>Improved mentation at present. MOnitor mental status going forward.  </td></tr><tr><td ID="instructionpot23">Dementia in other diseases classified elsewhere, mild, with mood disturbance</td><td>Improved mentation at present. MOnitor mental status going forward.  </td></tr><tr><td ID="instructionpot24">Benign prostatic hyperplasia with lower urinary tract symptoms</td><td><p/><p> </p><p>  </p><p>  Mild symptoms can be decreased by reducing you liquid</p><p>  intake, avoiding caffeine and alcohol and by preventing constipation. Monitor</p><p>  symptoms.    </p></td></tr><tr><td ID="instructionpot25">Other obstructive and reflux uropathy</td><td><p/><p> </p><p>  </p><p>  Mild symptoms can be decreased by reducing you liquid</p><p>  intake, avoiding caffeine and alcohol and by preventing constipation. Monitor</p><p>  symptoms.</p><p>    </p></td></tr><tr><td ID="instructionpot26">Thrombocytopenia</td><td>Monitor for now. Follow-up. </td></tr><tr><td ID="instructionpot27">Major depressive disorder, recurrent, moderate</td><td>monitor, continue current meds  </td></tr><tr><td ID="instructionpot28">Swelling of left lower extremity</td><td>Presentation more c/w phlebitis, but need to rule out DVT.  Cover with Augmentin bid / elevate / warm compresses. Check STAT DUPLEX US TO RULE-OUT DVT. </td></tr></tbody></table><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">Hemoglobin A1c-001453</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">CBC With Differential/Platelet-005009</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">Lipid Panel w/ Chol/HDL Ratio-221010</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">Comp. Metabolic Panel (12)-302085</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 02:30:00 PM, [REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 03:30:00 PM, [REDACTED][REDACTED]-1161, [REDACTED]</td></tr><tr><td ID="futureAppt3">Provider Name:[REDACTED], [REDACTED] 02:00:00 PM, [REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt4">Provider Name:[REDACTED], [REDACTED] 01:00:00 PM, [REDACTED]-1161, [REDACTED]</td></tr><tr><td ID="futureAppt5">Provider Name:[REDACTED], [REDACTED] 01:00:00 PM, [REDACTED]-1161, [REDACTED]</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 242843 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td>UNLOCKED PROGRESS NOTE</td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>242843</td><td align="right"><span class="bold">Provider: </span>[REDACTED], MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>79 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. Follow up. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Allergic rhinitis</span>: <br/>       [REDACTED] male here to review ongoing medical therapy for <span class="bold">CAD S/P CABG, HYPERTENSION, HYPERCHOLESTEROLEMIA, NIDDM WITH NEUROPATHY, GERD, BPH, DEPRESSION, OSTEOARTHRITIS. </span><br/><br/>[REDACTED] with CABG. No CP or SOB, but LLE swelling about harvest site / calf. <br/><br/>Admitted to hospital in April with BRBPR. Labs stable and presumed bleeding diverticula. Met with Dr. Mompi and Colonoscopy will need to be rescheduled.  <br/><br/>CXR with mediastinal fullness- CT CHEST [REDACTED]: COPD with 2mm  noncalcified nodule and calcified grandulomata LUL. <br/><br/><span class="bold">Meds: ASA 81G/ PLAVIX 75MG, METFORMIN 500MG BID, GLIMEPIRIDE 4MG BID, METOPROLOL TART 25MG BID, FUROSEMIDE 20MG, ATORVASTATIN 80MG DAILY, PANTOPRAZOLE 40G, SUCRALFATE 1GM, BID-QID, CYMBALTA 30MG DAILY, SEROQUEL 25MG HS, FINASTERIDE 5MG, TAMSULOSIN 0.4MG.  </span><br/><br/>LABS:[REDACTED]: H/H=15.1/45.2; BUN/CR=34/1.0; 12/21/223: BUN/CR=20/1.04; BS=406; A1C=14.4; CHOL=200; HDL=44; LDL=113; TRIG=251;  [REDACTED]: BUN/CR=20/1.04; BS=282; A1C=9.6; MICROALBUMIN-NEGATIVE; CHOL=191; HDL=38; LDL=119; TRIG=195; [REDACTED]: BS=149; A1C=6.7; MICROALBUMIN-NEGATIVE; CBC,CMP-WNL; CHOL=174; HDL=38; LDL=102; TRIG=194; [REDACTED]: CBC,CMP-WNL; BS=123; A1C=6.3; PSA=0.3; CHOL=135; HDL=36; LDL=77; TRIG=123.F.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> HYPERTENSION  W/ CKD-2, HYPERCHOLESTEROLEMIA, NIDDM W/ PAD / NEUROPATHY, OSTEOARTHRITIS  /  LUMBAR DEGENERATIVE DISC DISEASE, GERD, BPH, ANXIETY   /  DEPRESSION.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Unknown Amoxicillin-Pot Clavulanate 875-125 MG Tablet one tablet with food Orally twice a day , Unknown Carvedilol 6.25 MG Tablet TAKE 1 TABLET BY MOUTH TWICE DAILY WITH FOOD   , Unknown cloNIDine HCl 0.1 MG Tablet one tablet Orally Twice a day , Unknown Diclofenac Sodium 75 MG Tablet Delayed Release 1 tablet as needed Orally Twice a day , Unknown DULoxetine HCl 30 MG Capsule Delayed Release Particles 1 capsule Orally Once a day , Unknown Gabapentin 300 MG Capsule 1 capsule Orally Three times per day AC , Unknown Glimepiride 4 MG Tablet 1 tablet before a meal Orally twice a day , Unknown Meloxicam 15 MG Tablet 1 tablet Orally Once a day , Unknown metFORMIN HCl 500 MG Tablet 1 tablet with a meal Orally twice a day , Unknown Sildenafil Citrate 100 MG Tablet 1 tablet as needed Orally Once a day , Unknown traMADol HCl 50 MG Tablet 1 tablet as needed Orally Twice a day for NON-ACUTE PAIN , Unknown Aspirin 81 MG Tablet Delayed Release 1 tablet Orally Once a day , Unknown Finasteride 5 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY Orally Once a day , Unknown Fluconazole 100 MG Tablet 1 tablet Orally once a week , Unknown Latanoprost 0.005 % Solution 1 drop into affected eye in the evening Ophthalmic Once a day , Unknown ReliOn True Metrix Test Strips test strips test strips USE DAILY AS DIRECTED   , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*, Unknown True Metrix Air Glucose Meter w/Device Kit dermally dermally twice a day , Notes to Pharmacist: Dx: E11.42, Unknown True metrix lancets lancets lancets USE DAILY AS DIRECTED   , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*, Unknown True Metrix Pro Blood Glucose - Strip dermally dermally testing twice a day , Notes to Pharmacist: Dx: E11.42, Unknown Clopidogrel Bisulfate 75 MG Tablet 1 tablet Orally Once a day , Unknown Lipitor 80 MG Tablet 1 tablet Orally Once a day , Unknown Furosemide 40 MG Tablet 1/2 tablet Orally Once a day , Unknown QUEtiapine Fumarate 25 MG Tablet 1 tablet at bedtime Orally Once a day , Unknown Sucralfate 1 GM Tablet 1 tablet on an empty stomach Orally Four times a day As needed</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> enalapril: angioedema - Side Effects, ACE INHIBITORS, lisinopril: lip swollen, Statins: myalgias - Side Effects. </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> <br/></td></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Coronary artery disease involving coronary bypass graft of native heart with unstable angina pectoris - I25.700 (Primary)   2. Non-ST elevation MI (NSTEMI) - I21.4   3. S/P left atrial appendage ligation - Z98.890   4. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I12.9   5. Chronic kidney disease, stage 2 (mild) - N18.2   6. Hypercholesteremia - E78.00   7. Atherosclerosis of aorta - I70.0   8. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene - E11.51   9. Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin - E11.42   10. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22   11. Type 2 diabetes mellitus with diabetic neuropathy, unspecified - E11.40   12. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin - E11.69   13. Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type - K92.2   14. Gastro-esophageal reflux disease without esophagitis - K21.9   15. ISCHEMIC COLITIS - K55.9   <content><span class="bold">Notes : </span>[REDACTED]</content>   16. Primary osteoarthritis involving multiple joints - M15.9   17. Spinal enthesopathy, multiple sites in spine - M46.09   18. Opioid dependence, uncomplicated - F11.20   19. Age-related osteoporosis without current pathological fracture - M81.0   20. Erectile dysfunction due to arterial insufficiency - N52.01   21. Degenerative disease of nervous system, unspecified - G31.9   22. Alzheimer's disease with early onset - G30.0   23. Dementia in other diseases classified elsewhere, mild, with mood disturbance - F02.A3   24. Benign prostatic hyperplasia with lower urinary tract symptoms - N40.1   25. Other obstructive and reflux uropathy - N13.8   26. Thrombocytopenia - D69.6   27. Major depressive disorder, recurrent, moderate - F33.1   28. Swelling of left lower extremity - M79.89   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Coronary artery disease involving coronary bypass graft of native heart with unstable angina pectoris</span> <br/>Notes: Maintain good control of BP and Lipids, Monitor for symptoms. Maintain good control of BP and Lipids, Monitor for symptoms.  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Non-ST elevation MI (NSTEMI)</span> <br/>Notes: Maintain good control of BP and Lipids, Monitor for symptoms.   </td></tr><tr><td/></tr><tr><td><span class="bold">3. S/P left atrial appendage ligation</span> <br/>Notes: Monitor for now. Follow- up   </td></tr><tr><td/></tr><tr><td><span class="bold">4. Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Refill Carvedilol Tablet, 6.25 MG, TAKE 1 TABLET BY MOUTH TWICE DAILY WITH FOOD, 90, 180 Tablet, Refills 3; Refill cloNIDine HCl Tablet, 0.1 MG, one tablet, Orally, Twice a day, 90 days, 180, Refills 3.  <br/>     <span class="Underline">LAB: Comp. Metabolic Panel (12)-302085</span><br/>Notes: Low Sodium Diet, Weight Reduction. Monitor.   </td></tr><tr><td/></tr><tr><td><span class="bold">5. Chronic kidney disease, stage 2 (mild)</span> <br/>Notes: In order to preserve renal function we need strict control of blood pressure - which should be less than 140/90 per JNC-8 guidelines; strict control of the LDL cholesterol which should be below 100, using statins if necessary. I encourage you to drink 50 ounces of fluids daily, and follow a low sodium diet. Avoid nephrotoxins (like NSAIDs). Monitor.   </td></tr><tr><td/></tr><tr><td><span class="bold">6. Hypercholesteremia</span> <br/>     <span class="Underline">LAB: Lipid Panel w/ Chol/HDL Ratio-221010</span><br/>Notes: Low cholesterol / high fiber diet. Monitor.   </td></tr><tr><td/></tr><tr><td><span class="bold">7. Atherosclerosis of aorta</span> <br/>Notes: Maintain good control of BP and LIPIDS. Monitor for symptoms.   </td></tr><tr><td/></tr><tr><td><span class="bold">8. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</span> <br/>Notes: GLIMEPIRIDE TO 4MG BID W/ METFORMIN 500MG BID. Monitor vacular signs and symptoms going forward - pvd present as a complication of diabetes.<br/><br/><br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Type 2 diabetes mellitus with diabetic polyneuropathy, without long-term current use of insulin</span> <br/>Refill Gabapentin Capsule, 300 MG, 1 capsule, Orally, Three times per day AC, 90 days, 270, Refills 1; Refill Diclofenac Sodium Tablet Delayed Release, 75 MG, 1 tablet as needed, Orally, Twice a day, 90 days, 180, Refills 3.  <br/>     <span class="Underline">LAB: Hemoglobin A1c-001453</span><br/>Notes: he REFUSES insulin or any injectable therapy. . Monitor neurologic signs and symptoms going forward - neuropathy present as a complication of diabetes.   </td></tr><tr><td/></tr><tr><td><span class="bold">10. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Start Glimepiride Tablet, 4 MG, 1 tablet before a meal, Orally, twice a day, 90 days, 180, Refills 3; Start metFORMIN HCl Tablet, 500 MG, 1 tablet with a meal, Orally, twice a day, 90 days, 180, Refills 3.  <br/>Notes: Adjust therapy to improve A1C- follow-up to monitor A1C. GFR, and urine proteins.<br/>he REFUSES insulin or any injectable therapy.<br/><br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Type 2 diabetes mellitus with diabetic neuropathy, unspecified</span> <br/>Notes: Stressed healthy diet and maintaining a healthy weight. Encourage monitoring blood glucose levels between office visits. Adjust therapy to improve A1C and BP levels- follow-up to monitor A1C, GFR, and urine proteins. \  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Type 2 diabetes mellitus with other specified complication, without long-term current use of insulin</span> <br/>Notes: Monitor cardiovascular signs and symptoms going forward- Hyperlipidemia present as a complication of diabetes  </td></tr><tr><td/></tr><tr><td><span class="bold">13. Gastrointestinal hemorrhage, unspecified gastrointestinal hemorrhage type</span> <br/>Notes: Followup with Dr. Mompi. Colonoscopy study pending.    </td></tr><tr><td/></tr><tr><td><span class="bold">14. Gastro-esophageal reflux disease without esophagitis</span> <br/>Notes: Watch alcohol, eating too close to bedtime, chocolate, caffeine, greasy, spicy, and acidic foods. Monitor symptoms.   </td></tr><tr><td/></tr><tr><td><span class="bold">15. ISCHEMIC COLITIS</span> <br/>Notes: Monitor for now. Follow- up  </td></tr><tr><td/></tr><tr><td><span class="bold">16. Primary osteoarthritis involving multiple joints</span> <br/>Refill traMADol HCl Tablet, 50 MG, 1 tablet as needed, Orally, Twice a day for NON-ACUTE PAIN, 30 days, 60, Refills 0; Start Meloxicam Tablet, 15 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 0.  <br/>Notes: The patient meets established guidelines for the management of non-malignant pain. Discussed the risks, benefits, and side effects of medication treatment including but not limited to medication abuse, tolerance, sedation, addiction and dependence. The PDMP (Eforsce) and random drug screenings are monitored for compliance. Current therapy improved the patient's functional capacity and quality of life.   </td></tr><tr><td/></tr><tr><td><span class="bold">17. Spinal enthesopathy, multiple sites in spine</span> <br/>Notes: Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms.   </td></tr><tr><td/></tr><tr><td><span class="bold">18. Opioid dependence, uncomplicated</span> <br/>Notes: Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high-risk situations; Use has resulted in a reduction of recreational, social and/or occupational activities; Note: Physical dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy. Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use;  </td></tr><tr><td/></tr><tr><td><span class="bold">19. Age-related osteoporosis without current pathological fracture</span> <br/>Notes: Supplement calcium and Vitamin D. DEXA every two years.   </td></tr><tr><td/></tr><tr><td><span class="bold">20. Erectile dysfunction due to arterial insufficiency</span> <br/>Start Sildenafil Citrate Tablet, 100 MG, 1 tablet as needed, Orally, Once a day, 30 day(s), 30, Refills 5.  <br/>Notes: Usually, a man takes 1 tablet 30 minutes to 1 hour before he plans to have sex. Sildenafil works for 4-8 hours; vardenafil works for up to 8 hours; and tadalafil works for up to 36 hours. You should not take more than 1 dose in 24 hours. Possible side effects: flushing, stomach upset, runny nose or vision changes are rare.  </td></tr><tr><td/></tr><tr><td><span class="bold">21. Degenerative disease of nervous system, unspecified</span> <br/>Refill DULoxetine HCl Capsule Delayed Release Particles, 30 MG, 1 capsule, Orally, Once a day, 90 days, 90, Refills 3.  <br/>Notes: Monitor for now. Follow-up.   </td></tr><tr><td/></tr><tr><td><span class="bold">22. Alzheimer's disease with early onset</span> <br/>Notes: Improved mentation at present. MOnitor mental status going forward.    </td></tr><tr><td/></tr><tr><td><span class="bold">23. Dementia in other diseases classified elsewhere, mild, with mood disturbance</span> <br/>Notes: Improved mentation at present. MOnitor mental status going forward.    </td></tr><tr><td/></tr><tr><td><span class="bold">24. Benign prostatic hyperplasia with lower urinary tract symptoms</span> <br/>Notes: <content><content><content><span class="content_span">Mild symptoms can be decreased by reducing you liquidintake, avoiding caffeine and alcohol and by preventing constipation. Monitorsymptoms.    </span></content></content></content>  </td></tr><tr><td/></tr><tr><td><span class="bold">25. Other obstructive and reflux uropathy</span> <br/>Notes: <content><content><content><span class="content_span">Mild symptoms can be decreased by reducing you liquidintake, avoiding caffeine and alcohol and by preventing constipation. Monitorsymptoms.</span></content></content></content>  </td></tr><tr><td/></tr><tr><td><span class="bold">26. Thrombocytopenia</span> <br/>     <span class="Underline">LAB: CBC With Differential/Platelet-005009</span><br/>Notes: Monitor for now. Follow-up.   </td></tr><tr><td/></tr><tr><td><span class="bold">27. Major depressive disorder, recurrent, moderate</span> <br/>Notes: monitor, continue current meds    </td></tr><tr><td/></tr><tr><td><span class="bold">28. Swelling of left lower extremity</span> <br/>Start Amoxicillin-Pot Clavulanate Tablet, 875-125 MG, one tablet with food, Orally, twice a day, 10 day(s), 20, Refills 0.  <br/>Notes: Presentation more c/w phlebitis, but need to rule out DVT.  Cover with Augmentin bid / elevate / warm compresses. Check STAT DUPLEX US TO RULE-OUT DVT.   </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronic signature of [REDACTED] , MD, ME136062  on [REDACTED] 04:15 PM EDT</td></tr><tr><td valign="top">Sign off status: Pending</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span"/></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], MD</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 04:15 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/>
</body></html>